Found: 4
Select item for more details and to access through your institution.
MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10739, doi. 10.1038/ncomms10739
- By:
- Publication type:
- Article
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.
- Published in:
- Oncogene, 2005, v. 24, n. 56, p. 8259, doi. 10.1038/sj.onc.1208989
- By:
- Publication type:
- Article
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 4, p. 1794, doi. 10.1172/JCI69927
- By:
- Publication type:
- Article
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
- Published in:
- Nature Medicine, 2010, v. 16, n. 8, p. 903, doi. 10.1038/nm.2187
- By:
- Publication type:
- Article